[{"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "64.99", "Date_of_Payment": "07/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "318469290", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELITEK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "24.41", "Date_of_Payment": "10/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189903692", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Pomalyst", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "19.79", "Date_of_Payment": "06/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197882426", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "18.71", "Date_of_Payment": "12/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "256038264", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FASLODEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "16.39", "Date_of_Payment": "01/07/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184766596", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Halaven", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "E.R. Squibb & Sons, L.L.C.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005499", "Total_Amount_of_Payment_USDollars": "15.53", "Date_of_Payment": "09/09/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "14021018", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ERBITUX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "15.00", "Date_of_Payment": "07/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216434", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "TAFINLAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "14.78", "Date_of_Payment": "01/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "197882428", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.73", "Date_of_Payment": "12/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216442", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "MEKINIST", "Name_of_Associated_Covered_Drug_or_Biological2": "SANDOSTATIN LAR", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "14.65", "Date_of_Payment": "10/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "137908936", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "CYRAMZA", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ipsen Biopharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000123", "Total_Amount_of_Payment_USDollars": "14.56", "Date_of_Payment": "04/23/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "341511187", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Somatuline Depot 120mg-.5ml", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "14.47", "Date_of_Payment": "10/17/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111773602", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "TARCEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "14.35", "Date_of_Payment": "03/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297421886", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Aranesp", "Name_of_Associated_Covered_Drug_or_Biological2": "Nplate", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "14.31", "Date_of_Payment": "05/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "188618368", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JEVTANA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ipsen Biopharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000123", "Total_Amount_of_Payment_USDollars": "14.20", "Date_of_Payment": "02/04/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "341503722", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Somatuline Depot 120mg-.5ml", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "14.18", "Date_of_Payment": "04/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216430", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VOTRIENT RCC", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "14.12", "Date_of_Payment": "01/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "256256022", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FASLODEX", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Medivation Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010858", "Total_Amount_of_Payment_USDollars": "14.07", "Date_of_Payment": "02/04/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "221237348", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "13.71", "Date_of_Payment": "11/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111747658", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XTANDI", "Name_of_Associated_Covered_Drug_or_Biological2": "TARCEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "13.56", "Date_of_Payment": "04/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216444", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SANDOSTATIN LAR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "13.48", "Date_of_Payment": "05/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216428", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SANDOSTATIN LAR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "13.37", "Date_of_Payment": "01/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "328301004", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "13.24", "Date_of_Payment": "09/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189834714", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "12.85", "Date_of_Payment": "04/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319241884", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ELITEK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "EISAI INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "12.80", "Date_of_Payment": "12/08/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "337967092", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "HALAVEN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "12.70", "Date_of_Payment": "02/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216448", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARYDAK", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "12.16", "Date_of_Payment": "06/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297421890", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Aranesp", "Name_of_Associated_Covered_Drug_or_Biological2": "XGEVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "LILLY USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "12.12", "Date_of_Payment": "06/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "137599604", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "CYRAMZA", "Name_of_Associated_Covered_Drug_or_Biological2": "ALIMTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.04", "Date_of_Payment": "10/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270041158", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "IMBRUVICA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "12.02", "Date_of_Payment": "08/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "330840715", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.00", "Date_of_Payment": "08/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270041162", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Imbruvica", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "SANOFI-AVENTIS U.S. LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000076", "Total_Amount_of_Payment_USDollars": "11.91", "Date_of_Payment": "01/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "319055862", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "JEVTANA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "11.77", "Date_of_Payment": "01/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "320089720", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PROMACTA", "Name_of_Associated_Covered_Drug_or_Biological2": "VOTRIENT", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "11.68", "Date_of_Payment": "12/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216440", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "VOTRIENT RCC", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "11.48", "Date_of_Payment": "04/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267830512", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "CYRAMZA", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "11.37", "Date_of_Payment": "10/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189844558", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Abraxane", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "11.25", "Date_of_Payment": "04/08/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184755168", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Halaven", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "11.12", "Date_of_Payment": "08/06/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "152466700", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Halaven", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "11.12", "Date_of_Payment": "03/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216446", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ZYKADIA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.90", "Date_of_Payment": "08/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216438", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TASIGNA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Lilly USA, LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000066", "Total_Amount_of_Payment_USDollars": "10.82", "Date_of_Payment": "02/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "267830514", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ALIMTA", "Name_of_Associated_Covered_Drug_or_Biological2": "CYRAMZA", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "10.67", "Date_of_Payment": "06/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270041170", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Zytiga", "Name_of_Associated_Covered_Drug_or_Biological2": "Imbruvica", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "10.66", "Date_of_Payment": "07/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216436", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "FARYDAK", "Name_of_Associated_Covered_Drug_or_Biological2": "TASIGNA", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Amgen Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000203", "Total_Amount_of_Payment_USDollars": "10.41", "Date_of_Payment": "01/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "297421880", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Aranesp", "Name_of_Associated_Covered_Drug_or_Biological2": "Nplate", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "10.34", "Date_of_Payment": "01/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317931356", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Rituxan", "Name_of_Associated_Covered_Drug_or_Biological2": "GAZYVA", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Celgene Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000343", "Total_Amount_of_Payment_USDollars": "10.25", "Date_of_Payment": "07/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189900960", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Revlimid", "Name_of_Associated_Covered_Drug_or_Biological2": "Istodax", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "9.55", "Date_of_Payment": "05/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216432", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TASIGNA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "301491", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "NOVARTIS PHARMACEUTICALS CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "7.82", "Date_of_Payment": "01/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "263216450", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AFINITOR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}]